Exploring the Upper Limits of Cerebral Perfusion Pressure in Pediatric Traumatic Brain Injury: A STARSHIP Analysis

Stefan Yu Bögli1,2, Ihsane Olakorede3, Claudia Ann Smith3

  • 1Brain Physics Laboratory, Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. stefanyu.boegli@usz.ch.

Neurocritical Care
|September 8, 2025
PubMed

Insights

High cerebral perfusion pressure (CPP) may not worsen outcomes in pediatric traumatic brain injury (TBI). This study suggests current guidelines might be too strict, but more research is needed to confirm safety and efficacy in TBI patients.

Area of Science:

  • Pediatric neurocritical care
  • Traumatic brain injury research
  • Cerebrovascular physiology

Background:

  • Low cerebral perfusion pressure (CPP) is a known poor prognostic marker in pediatric traumatic brain injury (TBI).
  • Cerebrovascular autoregulation normally maintains stable cerebral blood flow, but high CPP can disrupt this, increasing risks.
  • The pediatric response to high CPP is less understood, prompting investigation into its upper autoregulation limit and impact on outcomes.

Purpose of the Study:

  • To characterize the upper limit of autoregulation in children with TBI.
  • To investigate the association between high CPP levels and patient outcomes.

Main Methods:

  • Analysis of data from the prospective, multicenter STARSHIP study (135 children with TBI).
  • Exploration of the relationship between CPP levels and the pressure reactivity index (PRx) using visual and statistical methods.
  • Assessment of CPP's prognostic value through overall averages, dose metrics, and time spent above thresholds.

Main Results:

  • No definitive upper limit of autoregulation was identified; PRx increased significantly only above 100 mm Hg.
  • Hourly CPP dose and time spent above 90 mm Hg showed a trend toward worse outcomes.
  • Heatmap analysis identified CPP regions with varying risk stratifications.
  • No significant CPP differences were observed between patients with or without ARDS or secondary hemorrhages.

Conclusions:

  • Contrary to expectations, high CPP levels (above current guidelines) may not be associated with worse outcomes in this pediatric TBI cohort.
  • The observational nature and potential confounders necessitate caution in interpreting these findings.
  • Prospective trials are required to definitively assess the safety and efficacy of targeting higher CPP in pediatric TBI management.
Abstract